College Students and Smoking Cessation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00941395|
Recruitment Status : Completed
First Posted : July 17, 2009
Last Update Posted : June 22, 2017
This study will help to establish the feasibility of a new smoking cessation and prevention intervention including two new modules addressing alcohol use and depression. In addition, we will demonstrate the feasibility of a smoking prevention website. Both cessation and prevention programs will be tailored to the needs of culturally diverse urban (University of Houston) and rural (Texas A&M) university campuses.
|Condition or disease||Intervention/treatment||Phase|
|Smoking Cessation Habits Smoking||Behavioral: Survey Behavioral: Counseling||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||39 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Enhanced Smoking Cessation for University Students|
|Actual Study Start Date :||June 30, 2009|
|Actual Primary Completion Date :||June 8, 2017|
|Actual Study Completion Date :||June 8, 2017|
Smoking Cessation Intervention
Completion of 3 surveys on the internet over the 3 months between the 1-week visit and the 3-month visit. The surveys should take about 20 minutes to complete.
Other Name: QuestionnaireBehavioral: Counseling
Individual in-person study visits at 1 week, 3 months, and 6 months.
Smoking Prevention Intervention
In-person end of study visit at 6 months.Behavioral: Survey
3 Internet-based surveys over 3 months, each taking approximately 20 minutes.
Other Name: Questionnaire
- Feasibility of smoking cessation program, using comparison of pre and post knowledge scores. [ Time Frame: Baseline and 6 month post intervention ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00941395
|United States, Texas|
|Texas A&M University|
|College Station, Texas, United States, 77843|
|University of Houston Central Campus|
|Houston, Texas, United States, 77004|
|Study Chair:||Alex Prokhorov, MD, PHD||M.D. Anderson Cancer Center|